Clinical Trial

A Study in Healthy Subjects to Compare the Bioavailability of EPA + DHA

Study acronym: GOBO
Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This is a randomised, double-blind, parallel, placebo-controlled study in healthy subjects to compare the absorption of two microalgal formulations, to a fish oil and a placebo.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2024-10-03; most recent amendment 2025-11-16.
Status change: Recruiting → Active, Not Recruiting 2025-09-18
Status change: Not Yet Recruiting → Recruiting 2025-08-18
Trial Details
NCT Number NCT06629103
Lead Sponsor RDC Clinical Pty Ltd
Conditions Optimal Absorption of Omega-3, Healthy
Enrollment 120 participants
Start Date 2025-08-06
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2025-11-18